INSM
Insmed·NASDAQ
--
--(--)
--
--(--)
4.83 / 10
Netural
Capital flow assessment yields 7.72/10, denoting robust fund flow characteristics. Strengths in no significant trends trends confront pressures from overall, block, Small, Medium, Large, and Extra-large patterns, resulting in positive liquidity outlook. Analyst consensus points to overwhelmingly bullish analyst consensus with strong conviction. Distribution analysis: Strong Buy(25.0%), Buy(50.0%), Neutral(25.0%) among 4 research opinions, supported by 1.94 historical weighted rating.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
25%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-23
InstitutionRoth Capital
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of INSM?
- INSM holds a Bearish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.83/10 (Netural).
